Brief: Heat Biologics Announces Strategy & Anticipated Q2 Milestones For Covid-19 Vaccine Program

Scorpius Holdings

29/04/2020 13:42

April 29 (Reuters) - Heat Biologics Inc  HTBX.O :
    * HEAT BIOLOGICS - ANNOUNCED STRATEGY & ANTICIPATED Q2 2020
MILESTONES FOR COVID-19 VACCINE PROGRAM
    * HEAT BIOLOGICS - ANTICIPATED Q2 MILESTONES INCLUDE
COMPLETION OF
DEVT OF A CELL-BASED VACCINE EXPRESSING GP96-IG, OX40L-IG, 
SARS-COV-2 PROTEIN S
    * HEAT BIOLOGICS - ANTICIPATED Q2 MILESTONES INCLUDE
SUBMISSION OF
GRANT APPLICATIONS TO FUND AND ACCELERATE COVID-19 VACCINE
DEVELOPMENT
    * HEAT BIOLOGICS - COMMENCEMENT OF PRECLINICAL TESTING OF
COVID-19
VACCINE PLANNED TO COMMENCE THIS QUARTER, WILL REPORT PRELIM
DATA SHORTLY THEREAFTER

Source: (https://bit.ly/2YfvFmQ)
Further company coverage:  HTBX.O 

 ((Reuters.Briefs@thomsonreuters.com;))